Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

U.S. Biotech Makes 'The Acquisition We Were Waiting For'

By tucking in this retinal gene therapy firm, the Massachusetts-based company gains assets and synergy. In a March 4 BTIG research note, analyst Thomas Shrader reported that Biogen Inc. (BIIB:NASDAQ) entered into an agreement to acquire Nightstar Therapeutics Pl...
Streetwise Reports | March 7, 2019 |

Oncology Vaccine Developer's Lead Programs 'On Track or Better'

The biopharma's two assets are discussed and Q1/19 financial results are provided in a BTIG research report. In a May 13 research note, BTIG analyst Thomas Shrader reported that Gritstone Oncology Inc.'s (GRTS:NASDAQ) lead clinical programs, GRANITE and SL...
Streetwise Reports | May 27, 2019 |

Biopharma Buys 'Insurance Policy Ahead of First Commercial Launch'

The terms of the financial transaction and the potential reasons for it are discussed in a BTIG report. In a June 26 research note, BTIG analyst Thomas Shrader reported that Esperion Therapeutics Inc. (ESPR:NASDAQ) agreed to an "up to $200 capped, tier...
Streetwise Reports | July 3, 2019 |

Topline Results from Lipid-Lowering Trial 'Just What the Doctor Ordered'

The study data and their implications are provided in a BTIG report. In an Aug. 29 research note, BTIG analyst Thomas Shrader reported that just released topline data are "as hoped" from Esperion Therapeutics Inc.'s (ESPR:NASDAQ) Phase 2 trial of bempedoic acid-ezet...
Streetwise Reports | September 5, 2019 |

When Will it be Safe to Jump Back into the Gold and Silver Pool?

Once again the DSI (Daily Sentiment Indicator) made an accurate call on a major top in gold and silver. The DSI reached nosebleed territory for gold about four weeks ago suggesting the metals were nearing shoal waters. Silver and platinum got stupid a week ago and I su...
Streetwise Reports | September 13, 2019 |

Antibody Developer Taken Out by Gilead at 'Hefty Premium'

The reasons Forty Seven attracted a buyer and its near-term catalysts are provided in a BTIG report. In a March 2 research note, BTIG analyst Robert Hazlett reported that Forty Seven Inc. (FTSV:NASDAQ) is being acquired by Gilead Sciences Inc. (GILD:NASDA...
Streetwise Reports | March 5, 2020 |

How Technology Helps Build Shareholder Perception

Technology is fundamentally changing business platforms and the way managers and executive directors plan, operate, manage, market, communicate and make a profit in business. In fact, some of the best-known brands and successful entrepreneurs focus on and are driven by t...
Lloyd Ainey | October 1, 2020 |

Oil Price Fundamental Daily Forecast – U.S. Supply Will Control Price Action This Week

The late price behavior on Friday and early Monday suggests crude oil traders have fully priced in the Phase One trade agreement. This means that investors will be looking for further news to push prices through the important technical resistance levels in order to extend the...
FX Empire | December 16, 2019 |

Tallgrass Energy Shares Rise 20% on Blackstone Partners Acquisition Deal

Shares of Tallgrass Energy LP traded 20% higher after the firm advised that it entered into a definitive merger agreement with Blackstone Infrastructure Partners to acquire all of the company's publicly held outstanding class A shares for $22.45 per share in cash. Mid...
Streetwise Reports | December 18, 2019 |

Remote Patient Monitoring: A Recurring Revenue Business Model that’s Moving Markets

Just about a year ago , we introduced our Stockhouse investor audience to a soon-to-be publicly listed company that was revolutionizing the digital and virtual healthcare space. Fast-forward to today and Cloud DX Inc. ( TSX-V.CDX , OTC: CDXFF , Forum ) is now publicly tr...
Dave Jackson | March 17, 2022 |
1 2 3 4 5 6 7